Many bacteria interact with target organisms using syringe-like structures called 25 Contractile Injection Systems (CIS). CIS structurally resemble headless bacteriophages 26 and share evolutionarily related proteins such as the tail tube, sheath, and baseplate 27 complex. Recent evidence shows that CIS are specialized to puncture membranes and 28 often deliver effectors to target cells. In many cases, CIS mediate trans-kingdom 29 interactions between bacteria and eukaryotes, however the effectors delivered to target 30 cells and their mode of action are often unknown. In this work, we establish an in vitro 31 model to study a CIS called Metamorphosis Associated Contractile structures (MACs) 32 that target eukaryotic cells. We show that MACs kill two eukaryotic cell lines, Fall
INTRODUCTION 41
Bacteria interact with eukaryotic organisms with outcomes ranging from pathogenic to 42 beneficial. One mechanism used by bacteria to interact with eukaryotes is through functional structures are still present. To determine whether the ∆JF50_12610 strain produces intact MAC structures, we 128 employed electron cryo-tomography (ECT). Upon inspection, MACs from wild type and 129 ∆JF50_12610 were indistinguishable; forming intact phage tail-like structures in both 130 extended and contracted conformations ( Figure 2N and O). In order to confirm that Pseudoalteromonas nuclease effector 1.
174
To determine whether Pne1 possesses nuclease activity, we cloned the wild type pne1 176 gene and a pne1-Glu328Ala mutant into an IPTG-inducible vector system with N- Glu328Ala proteins were still functional in the presence of EDTA ( Figure 3D ).
186
To test whether Pne1 requires its nuclear localization signal or the conserved Glu328 187 for killing insect cells, we created P. luteoviolacea mutants lacking the predicted nuclear In this work, we establish an in vitro interaction model between an eCIS and two 233 eukaryotic cell lines. With this system, we determined that the bacterial protein, Pne1, is 234 a novel eCIS effector and possesses nuclease activity. To our knowledge, our work is 235 the first to identify a CIS with broad eukaryotic host range and identify the first Rhizobium leguminosarum limits its host range to plants in the clover family by secreting 244 proteins through a T6SS, while mutation of the imp gene cluster (encoding components 245 of the T6SS) allowed the bacterium to form functional root nodules on pea plants, 246 normally outside of its host range (Bladergroen et al., 2003) . In the environment, In addition to expanding our basic understanding of CIS, our work opens the door for 273 potentially using eCIS for biotechnology purposes. eCIS that target bacterial pathogens 274 are already under development as narrow host-range antimicrobial agents (Scholl, et al., 2015) . As syringe-like structures that deliver proteinaceous cargo to eukaryotic 277 cells, we are currently working to develop MACs as potential delivery systems for 278 biotechnology applications. While the mechanism of any eCIS-eukaryotic cell 279 attachment has yet to be determined, it is tantalizing to imagine using genetically-280 modified CIS to deliver peptides of interest to specific eukaryotic cell types. The in vitro 281 system described in this work will significantly facilitate the realization of these efforts. All the strains and primers used throughout the experiments reported can be seen in 286 tables below (Table 1 , 2). All deletion and fusion strains were created according to 287 previously published protocols (Shikuma et al., 2014 (Shikuma et al., , 2016 . Plasmid insert sequences 288 were verified by DNA sequencing. Deletion and insert strains were confirmed by PCR. Subsequently, the supernatant was discarded and the pellet was resuspended in 5mL 304 of cold extraction buffer (20mM Tris Base, 1M NaCl, 1L of deionized water, adjust the 305 pH to 7.5 with HCl). The resuspension mixture was then transferred to a 15mL 306 centrifuge tube and placed in the centrifuge for another 20 minutes at 4000g at 4°C.
307
This time, the supernatant was transferred to another 15mL tube and spun down one 308 last time with the same above conditions. After this final spin, the supernatant (now 309 called MAC extract) was carefully poured to another clean 15mL tube and kept at 4°C 310 until it was ready to be used for cell infections. In some experiments, MAC extract was 311 filtered through a 0.45µm syringe filter. The resuspensions were centrifuged for 30 minutes at 4000 g and 4˚C and the 388 supernatant was isolated and centrifuged for 30 minutes at 7000 g and 4˚C. The pellet 389 was resuspended in 20-100µL cold extraction buffer and stored at 4°C for further use.
390
All mass spectrometry was done by the Functional Genomics Center Zurich (FGCZ). To range was −60° to +60° and the angular increment was 2°. The total electron dose was 414 between 60-100 electrons per Å 2 and the pixel size at specimen level was 2.72 Å.
415
Images were recorded in focus with a Volta phaseplate (ThermoFisher) for WT and 416 without phaseplate at 5 µm under-focus for ΔJF50_12610. Tilt series were aligned using 417 gold fiducials and three-dimensional reconstructions were calculated by weighted back Prior to exposure to MACs, J774A.1 cells were passaged two to five times and seeded 439 into 24-well tissue culture plates at a density of 4x10 5 cells/mL the night before the 440 treatment. MACs that were extracted no more than a week prior to cell treatment were 441 added to each well of the 24-well plates with cells at a 1:50 ratio (10µL of the extracts 442 into 500µl of cells). Treated cells were incubated at 37°C with 5% CO2. Culture 
